Propanc Biopharma plans to buy $100 million worth of Ethereum in the next 12 months

This article is machine translated
Show original

On September 2nd, Propanc Biopharma (PPCB), a US-listed biopharmaceutical company, announced plans to purchase $100 million worth of Ethereum over the next 12 months. Propanc Biopharma said the move would enhance its corporate strategy across various sectors, including cryptocurrency investment, drug development, and asset acquisitions.

Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments